subject: Abraxis Bioscience, Inc. (abii) Swot Profile---aarkstore Enterprise Market Research Aggregation [print this page] Summary Summary
Abraxis BioScience, Inc. (ABII) SWOT Profile is a comprehensive business, functional and strategic analysis of Abraxis BioScience, Inc.. The profile delves into the operations of the company to present an in-depth analysis of the various aspects related to its business. It analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, executive biographies and key competitors. The hallmark of the profile is the detailed strategic analysis of the company. This highlights and presents an unbiased view of its key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by understanding your partners, customers and competitors better.
Abraxis BioScience, Inc. (Abraxis) is a biotechnology company engaged in delivering therapeutics, such as Abraxane, and core technologies. These technologies offer safe and effective treatments for cancer and other critical illnesses to the patients and medical professionals. The company owns the worldwide rights to Abraxane, the first FDA approved product to use the nab platform for the treatment of metastatic breast cancer.
Key Recent Developments
Apr 19, 2010: Abraxis BioScience Updates On Overall Survival Findings From Phase I/II Study Of Nab-paclitaxel
Apr 13, 2010: SMC Accepts Abraxis BioScience Abraxane For Restricted Use Within NHS For Scotland
Mar 11, 2010: Abraxis BioScience Reports Net Loss Of $19 Million In Q4 2009
Scope
- Examines key information about company for business intelligence.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented objectively. Business, strategic and operational aspects are taken into account.
- Opportunities available to the company are sized up and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The profile contains valuable and critical company information business structure and operations, the company history, major products and services, prospects, key competitors, key employees, executive biographies, important locations and subsidiaries.
- The profile provides detailed financial ratios for the past five years as well as interim ratios for the last five interim periods for major public companies.
- Financial ratios presented for major public companies include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
